The report "Bioburden Testing Market by Product (Instrument (PCR, Microscopes), & Consumables (Kit, Reagent)), Test (Aerobic, Anaerobic, Fungi, Spore), Application (Raw Material, In-process) & End User (Pharmaceutical, Biotechnology, CMO) - Forecast to 2019”, provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the bioburden testing market along with estimates and forecasts of the revenue and share analysis.

The global bioburden testing market is expected to reach $565.6 Million by 2019 from $354.4 Million in 2014, growing at a CAGR of 9.8% from 2014 to 2019.

Browse 96 market data tables and 46 figures spread through 180 pages and in-depth TOC on “Bioburden Testing Market”
http://www.marketsandmarkets.com/Market-Reports/bioburden-testing-market-17983056.html
Industry Insights:
The report segments the bioburden testing market on the basis of products and services, test types, applications, end users, and regions. In the product segment, consumables accounted for the largest share in 2014; however, the culture media and reagents & kits segment will grow at the highest CAGR during the forecast period as culture media and reagents & kits are most commonly used for bioburden testing. Factors such as the growing medical device industry, changing trends in the pharmaceutical and biotechnology industries, increasing food safety concerns to boost the bioburden testing market, strong trend of R&D investments in life sciences, and increasing product recalls due to microbial contamination are driving the growth of the bioburden testing market.
Based on regions, the market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America is estimated to account for the largest share of the market in 2014, while Asia-Pacific is likely to witness the highest growth in the forecast period.
Get The PDF Brochure For This Report:
http://www.marketsandmarkets.com/pdfdownload.asp?id=17983056

Geographical Scenario:

The global microbial limit testing market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America will continue to dominate the market in the forecast period. Over the next five years, the growth of the market in the Asian region is likely to be centered on China and India.

Scope of the Report:
This research report covers the bioburden testing market by product, test type, applications, end user, and region.
Bioburden Testing Market, by Product:
• Consumables
• Instruments
Bioburden Testing Market, by Test Type
• Aerobic Count
• Anaerobic Count
• Fungi/Mold Count
• Spores Count
Bioburden Testing Market, by Application
• Raw Material Testing
• Medical Devices Testing
• In-process Testing
• Sterilization Validation Testing
Bioburden Testing Market, by End User
• Pharmaceutical and Biotechnology Companies
• Medical Device Manufacturers
• Contract Manufacturing Organizations (CMOs)
• Manufacturers of Food & Beverage and Agricultural Products
Bioburden Testing Market, by Region
• North America
• Europe
• Asia
• Rest of the World (RoW)
Request Sample of the report:
http://www.marketsandmarkets.com/requestsample.asp?id=17983056

Industry Leaders:

Key players in the bioburden testing market include Charles River Laboratories International, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), SGS S.A. (Switzerland), WuXi PharmaTech (Cayman) Inc. (China), Merck & Co., Inc. (U.S.), Becton, Dickinson and Company (U.S.), North American Science Associates, Inc. (NAMSA) (U.S.), Nelson Laboratories (U.S.), Pacific Biolabs (U.S.), and ATS Labs, Inc. (U.S.).


About MarketsandMarkets™:

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.


Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
E-mail: [email protected]
Tel: 1-888-600-6441